Dr. Michael Gluck has 30 years’ experience working with researchers, policymakers and other stakeholders to evidence-informed decision-making, drawing on his substantive knowledge of health care financing and delivery as well as science policy. He currently coordinates one of AcademyHealth’s areas of strategic focus – our efforts to innovate the way health services research is funded, incentivized, conducted, translated and communicated for health policy and practice. Dr. Gluck directs AcademyHealth’s international efforts including collaborations with health services research associations in other parts of the world, periodic study tours for US health care leaders, and our role in the Cochrane Collaboration’s US network. Since coming to AcademyHealth in 2009, Dr. Gluck has also supported the health policy-oriented research grantmaking we do on behalf of the Robert Wood Johnson Foundation and currently directs a Gordon and Betty Moore Foundation-funded research grant solicitation focused on understanding and addressing delays in diagnosis.
Dr. Gluck previously served as a senior analyst and project director at the Congressional Office of Technology Assessment, as Director of Health Policy at the National Academy of Social Insurance, as Associate Research Professor at Georgetown University’s Health Policy Institute, and as the first director of the University of California’s California Health Benefits Review Program. He received a bachelor’s in history magna cum laude from Haverford College and master’s and doctoral degrees in public policy from Harvard University.
Dr. Gluck's areas of expertise include Medicare, Medicaid, health care costs and financing, prescription drugs, technology assessment, science policy, research translation, dissemination, and implementation.
“I’ve spent my career at the intersection of research and policy, working to translate the technical information the health services research field produces. As the health care system changes, it’s been a rewarding experience co-directing AcademyHealth’s Translation and Dissemination Institute, which is committed to helping the HSR field find effective, innovative tools to help policymakers and other health care leaders use evidence we produce. Not every researcher needs to be a superstar communicator of their findings, but our field needs to work hard to assure that rigorous and relevant research reaches decision-makers.”